Research Areas
- Environmental Neurotoxicology, focusing on Manganese
- Neuroprotection mechanism via estrogenic compounds
- Transcriptional mechanisms of genes, such as YY1, REST, and LRRK2, involved in manganese-induced neurotoxicity
Scientific Achievements
- Understanding the roles of genes, YY1, REST and LRRK2, in manganese-induced Neurotoxicity mechanisms
- Understanding the potential role of environmental toxin manganese in the development of Parkinson’s disease.
- Understanding the potential therapeutic strategies using estrogenic compounds to treat manganese-induced neurotoxicity and other associated neurodegenerative disease
- R01 grant award: NIH/NIEHS R01 ES10563
Funding
RCMI Funding: NIH/NIMHD U54 MD007582
Scientific Advance
- The role of microglial LRRK2 kinase in manganese-induced inflammatory neurotoxicity via NLRP3 inflammasome and RAB10-mediated autophagy dysfunction. J Biol Chem. 299(7):104879. PMID: 37269951
- Dopaminergic REST/NRSF is protective against manganese-induced neurotoxicity in mice. J Biol Chem. 2024. 300(9):107707. PMID: 39178947
- Tamoxifen induces protection against manganese toxicity by REST upregulation via the ER-α/Wnt/β-catenin pathway in neuronal cells. J Biol Chem. 2025 Apr 23;301(6):108529. PMID: 40280417
Manganese is a heavy metal, but humans will be easily exposed to its high levels from the environment, including some pesticides and mines. If humans are exposed to high levels of manganese chronically, it can cause neurotoxicity, exhibiting Parkinson’s disease-like symptoms. But we do not know the toxicity mechanisms associated with its toxicity, and thus, no effective treatment is available. We are studying the toxicity mechanisms as well as the protection mechanisms. We test several genes, YY1, REST, and LRRK2, to determine if they are involved in manganese toxicity mechanisms. We also tested whether estrogenic compounds, such as tamoxifen, which induce neuroprotection in neurodegenerative diseases, can protect against manganese toxicity and the potential mechanism involved. This can lead to the development of estrogenic compounds, which specifically act on the brain without exerting side effects in the other parts of the body.
NIH/NIEHS #R01 ES031282, NIH/NIEHS #R01 ES10563, NIH/NIMHD #U54 MD007582
